Transaction DateRecipientSharesTypePriceValue
30th September 2020Capital, Llc Armistice0Open or private sale$0.00
30th September 2020Capital, Llc Armistice5,500Open or private sale$0.13$715.00
29th September 2020Capital, Llc Armistice0Open or private sale$0.00
29th September 2020Capital, Llc Armistice5,000Open or private sale$0.14$700.00
28th September 2020Capital, Llc Armistice0Open or private sale$0.00
28th September 2020Capital, Llc Armistice4,966Open or private sale$0.13$645.58
24th September 2020Capital, Llc Armistice38,257Open or private sale$0.13$4,973.41
24th September 2020Capital, Llc Armistice0Open or private sale$0.00
23rd September 2020Capital, Llc Armistice1,000Open or private purchase$3.91$3,910.00
23rd September 2020Capital, Llc Armistice0Open or private sale$0.00
Onconova Therapeutics
Onconova Therapeutics logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 8/10.


Onconova Therapeutics, Inc. focuses on discovering and developing small molecule drug candidates to treat cancer. The company was founded by Ramesh Kumar and E. Premkumar Reddy in 1998.


Ticker: ONTX
Sector: Health Technology
Industry: Biotechnology
SEC Central Index Key (CIK): 1130598
Employees: 19
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals